October 22, 2020
Video
Brad Glick gives an overview of new and exciting trends in the field of dermatology.
October 19, 2020
Article
FDA application is based on the positive data from 3 recent phase 3 clinical trials.
October 13, 2020
Though atopic dermatitis is a relatively common condition, most of the existing scientific literature has ignored the majority of patients who have mild or limited disease.
October 08, 2020
New research suggests the Janus kinase 1 and 2 inhibitor relieves symptoms of atopic dermatitis at a daily dose of 4 mg.
Newly published data show routine testing is unlikely to change the management of patients with CSU.
September 24, 2020
D. farinae and D. pteronyssinus positive skin prick test results were much more frequent in patients >18 years.
August 24, 2020
Patients impacted by pruritus were more depressed and anxious than a comparison control group.
August 19, 2020
More trials must include older patients in order to better understand the safety and efficacy of systemic treatments for atopic dermatitis.
August 13, 2020
The study addresses safety concerns related to the risk of keratinocyte carcinoma for patients with atopic dermatitis.
July 31, 2020
The FDA will be working over the next few months to ensure tralokinumab is efficient for atopic dermatitis.
